3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neuroendocrine Tumors
1
Interventions
Temozolomide
2
Everolimus
2
Capecitabine
2
Bevacizumab
2
regorafenib
1
pazopanib
1
motesanib diphosphate
1
batifiban
1
Sorafenib
1
Panobinostat
1
Oxaliplatin
1
Octreotide
1
Leucovorin
1
Fluorouracil
1
Fentanyl
1
Doxorubicin
1
Bortezomib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Insulinoma
×
177Lu-octreotide, DOTA(0)-Tyr(3)-
×
Clear all
No trials found.